Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cacao | 2 | 2024 | 98 | 1.710 |
Why?
|
Cholecalciferol | 5 | 2024 | 538 | 1.230 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2023 | 1367 | 1.010 |
Why?
|
Psychiatry | 7 | 2023 | 1683 | 0.900 |
Why?
|
Vitamins | 4 | 2024 | 1611 | 0.850 |
Why?
|
Depression | 8 | 2023 | 7826 | 0.820 |
Why?
|
Mental Disorders | 9 | 2024 | 6639 | 0.760 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2000 | 0.740 |
Why?
|
Aging | 5 | 2023 | 8486 | 0.690 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 684 | 0.680 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 835 | 0.610 |
Why?
|
Telomere | 2 | 2021 | 905 | 0.600 |
Why?
|
DNA Methylation | 2 | 2023 | 4259 | 0.570 |
Why?
|
Psychotic Disorders | 2 | 2023 | 3099 | 0.540 |
Why?
|
Depressive Disorder, Major | 2 | 2023 | 4687 | 0.510 |
Why?
|
Primary Prevention | 1 | 2020 | 1168 | 0.410 |
Why?
|
Life Style | 2 | 2021 | 3823 | 0.410 |
Why?
|
Dietary Supplements | 6 | 2024 | 3325 | 0.400 |
Why?
|
Hospitals, General | 7 | 2023 | 763 | 0.390 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3654 | 0.350 |
Why?
|
Clozapine | 2 | 2024 | 500 | 0.340 |
Why?
|
Double-Blind Method | 5 | 2024 | 12227 | 0.290 |
Why?
|
Thyroid Nodule | 3 | 2018 | 751 | 0.270 |
Why?
|
Cognition | 4 | 2024 | 6782 | 0.270 |
Why?
|
Aged | 21 | 2024 | 164383 | 0.260 |
Why?
|
Hypothyroidism | 3 | 2018 | 662 | 0.240 |
Why?
|
Affect | 2 | 2021 | 1459 | 0.220 |
Why?
|
Dyskinesias | 1 | 2024 | 81 | 0.220 |
Why?
|
Referral and Consultation | 7 | 2023 | 3545 | 0.210 |
Why?
|
Minerals | 1 | 2024 | 279 | 0.210 |
Why?
|
Antipsychotic Agents | 3 | 2024 | 3053 | 0.190 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25184 | 0.180 |
Why?
|
Dystonia | 1 | 2024 | 354 | 0.180 |
Why?
|
Movement Disorders | 1 | 2024 | 460 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10096 | 0.170 |
Why?
|
Humans | 34 | 2024 | 746630 | 0.170 |
Why?
|
Vitamin D | 3 | 2023 | 3240 | 0.170 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 595 | 0.170 |
Why?
|
Comorbidity | 3 | 2023 | 10372 | 0.160 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1419 | 0.150 |
Why?
|
Depressive Disorder | 2 | 2021 | 3744 | 0.150 |
Why?
|
Alzheimer Disease | 1 | 2019 | 8305 | 0.150 |
Why?
|
Pilot Projects | 2 | 2023 | 8378 | 0.150 |
Why?
|
Genetic Markers | 1 | 2023 | 2595 | 0.140 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 509 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2019 | 662 | 0.120 |
Why?
|
Executive Function | 1 | 2023 | 1346 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2023 | 12840 | 0.120 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2381 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 589 | 0.120 |
Why?
|
Epithelium | 1 | 2018 | 1609 | 0.110 |
Why?
|
Thyroidectomy | 1 | 2018 | 897 | 0.100 |
Why?
|
Male | 14 | 2024 | 351420 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5613 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2018 | 1168 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 6939 | 0.090 |
Why?
|
Female | 14 | 2024 | 382450 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1876 | 0.090 |
Why?
|
Smoking Cessation | 1 | 2022 | 2070 | 0.090 |
Why?
|
Health Surveys | 1 | 2020 | 3962 | 0.090 |
Why?
|
Genotype | 1 | 2024 | 12788 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1764 | 0.080 |
Why?
|
Middle Aged | 10 | 2021 | 214618 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3962 | 0.070 |
Why?
|
Carcinoma | 1 | 2018 | 2343 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3226 | 0.070 |
Why?
|
Schizophrenia | 2 | 2024 | 6838 | 0.070 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5050 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2299 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 21693 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5688 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1108 | 0.050 |
Why?
|
Paranoid Disorders | 1 | 2022 | 61 | 0.050 |
Why?
|
Restraint, Physical | 1 | 2023 | 184 | 0.050 |
Why?
|
Neoplasms | 2 | 2018 | 21715 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 382 | 0.040 |
Why?
|
Polypharmacy | 1 | 2020 | 301 | 0.040 |
Why?
|
Fish Oils | 1 | 2021 | 473 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 289 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 72447 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2616 | 0.030 |
Why?
|
Primary Health Care | 2 | 2022 | 4592 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11215 | 0.030 |
Why?
|
Ultrasonography | 2 | 2018 | 5901 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2018 | 433 | 0.030 |
Why?
|
United States | 1 | 2021 | 70437 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12645 | 0.030 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7703 | 0.030 |
Why?
|
Adult | 2 | 2023 | 215192 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57586 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2919 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 1995 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2018 | 78313 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8384 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12280 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15312 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4194 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 40534 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11050 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20820 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6419 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13317 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16261 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29079 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23464 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53253 | 0.010 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_